Antigenix Therapeutics is a startup based in the United States, most recent round Seed.
Antigenix Therapeutics is a company headquartered in the United States. Its most recent tracked round is Seed.
Antigenix Therapeutics develops antibody-based therapies for cancer treatment, focusing on targeted antibody-drug conjugate therapies to improve the precision and effectiveness against aggressive and treatment-resistant cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.